Last activity: 14.06.2024
Categories: CenterElectronicsHealthTechITMeasurementPersonalResearchSensorsSoftwareTechnology
Easy 24/7 blood pressure monitoring. Get stress-free readings round the clock with Aktiia's clinically validated blood pressure monitor
Location: Switzerland, Neuchâtel
Total raised: $58.47M

Investors 6

Funding Rounds 4

08.11.2021Series A$17.5MMolten Ven...

Mentions in press and media 41

14.06.2024CE Mark paves way for Aktiia international growth Since its inception in 2018, Aktiia has been a pioneer of blood pressure technology, known for its initial product – the first continuous BP monitoring device worn on the wrist, which currently requires monthly calibration. Today’s announc...
30.04.2024Swiss tech startups continue to win accolades worldwide Bionomous, RoBoa, and Mondaic Ltd. have secured coveted spots in the Zühlke Product Scale-Up Coaching program, a joint program offering CHF 20,000 business consulting and coaching package to selected companies. Additionally, the startups w...
16.04.2024Die (bisher) größten Startup-Investitionen des JahresTagtäglich investieren deutsche und ausländische Risikokapitalgeber in junge Startups bzw. aufstrebende Scaleups und reifere Grownups. Auch in den ersten drei Monaten des Jahres 2024 gab es schon wieder sehr viele spannende Geldströme in De...
10.04.2024Germany’s Proxima Fusion bags €20M in Seed funding to build first-generation fusion power plantsRead this article in: Munich-based Proxima Fusion, the first spin-out from the Max Planck Institute for Plasma Physics (IPP), announced on Wednesday that it has raised €20M in a seed funding round led by redalpine and oversubscribed. The Ba...
09.03.2024Aktiia Revolutionizes Blood Pressure MonitoringAktiia, a Swiss HealthTech company, secures USD 30M in funding to advance its mission of easing the global burden of hypertension through AI-driven technology. Led by Redalpine, the funding round includes investors like Khosla Ventures and ...
04.03.2024Aktiia: Wrist-Worn 24/7 Optical Blood Pressure Monitoring Company Raises CHF 27 MillionAktiia – the Swiss HealthTech innovator that developed the world’s first wrist-worn 24/7 optical blood pressure monitoring device – announced the completion of a CHF 27 million (USD 30M) funding round, led by Redalpine with participation fr...
01.03.2024Aktiia Secures USD 30M in FundingAktiia, a Neuchâtel, Switzerland-based HealthTech company providing optical blood pressure monitoring devices, raised USD 30M in funding. The round was led by Redalpine, with participation from Khosla Ventures, Molten, Translink Capital, Ve...
29.02.2024Enviria sammelt 200 Millionen ein – Aktiia bekommt 30 Millionen – CycloTech erhält 20 MillionenIm #DealMonitor für den 29. Februar werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-...
27.02.2024Aktiia banks CHF 27 million to mitigate hypertension worldwide Over 1.4 billion people worldwide are affected by high blood pressure, resulting in more than 18 million related deaths annually. This strategic infusion of capital will accelerate Aktiia's mission to ease the global burden of hypertension...
27.02.2024Aktiia secures CHF 27 million to accelerate innovation in hypertension managementAktiia secures CHF 27 million to accelerate innovation in hypertension management 27.02.2024 16:45, Rita Longobardi linkedIn facebook twitter instagram youtube --> Aktiia, a pioneer in blood pressure monitoring technology, has secured CH...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In